|
Treatment
|
Strain
|
CONT
|
CAST
|
CAST + T
|
|---|
|
Passive diameter (μm)
|
SHR
|
305.4 ± 22.9 (n = 9)
|
285.7 ± 14.5 (n = 12)
|
++274.3 ± 6.4 (n = 10)
|
| |
WKY
|
352.8 ± 26.0 (n = 8)
|
301.9 ± 10.9 (n = 8)
|
309.6 ± 10.1 (n = 14)
|
|
Wall thickness (μm)
|
SHR
|
*34.9 ± 2.5 (n = 9)
|
28.4 ± 2.3 (n = 12)
|
31.7 ± 3.4 (n = 10)
|
| |
WKY
|
24.1 ± 3.8 (n = 8)
|
22.2 ± 3.5 (n = 8)
|
23.9 ± 2.7 (n = 10)
|
|
Wall-to-lumen ratio
|
SHR
|
*0.117 ± 0.009 (n = 9)
|
+0.102 ± 0.009 (n = 12)
|
++0.124 ± 0.014 (n = 10)
|
| |
WKY
|
0.070 ± 0.001 (n = 8)
|
0.070 ± 0.010 (n = 8)
|
0.080 ± 0.010 (n = 12)
|
-
aCAST, castrate; CAST + T, castrate plus testosterone; CONT, control; SHR: spontaneously hypertensive rat; T: testosterone; WKY: Wistar Kyoto. Data are means ± SEM. *P < 0.05 for SHR CONT vs WKY CONT. +†
P < 0.05 for SHR CAST vs WKY CAST.++ ‡
P < 0.05 for SHR CAST + T vs WKY CAST + T.
